Gsa Capital Partners LLP Vera Therapeutics, Inc. Transaction History
Gsa Capital Partners LLP
- $1.32 Billion
- Q3 2024
A detailed history of Gsa Capital Partners LLP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 12,113 shares of VERA stock, worth $532,487. This represents 0.04% of its overall portfolio holdings.
Number of Shares
12,113
Previous 32,400
62.61%
Holding current value
$532,487
Previous $1.17 Million
54.35%
% of portfolio
0.04%
Previous 0.08%
Shares
5 transactions
Others Institutions Holding VERA
# of Institutions
184Shares Held
55.1MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$189 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$173 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$147 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$130 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$123 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.19B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...